126 related articles for article (PubMed ID: 10722966)
1. Clinical, fluorine-18 labeled 2-fluoro-2-deoxyglucose positron emission tomography (FDG PET), MRI of the brain and biochemical observations in a patient with 4-hydroxybutyric aciduria; a progressive neurometabolic disease.
Al-Essa MA; Bakheet SM; Patay ZJ; Powe JE; Ozand PT
Brain Dev; 2000 Mar; 22(2):127-31. PubMed ID: 10722966
[TBL] [Abstract][Full Text] [Related]
2. 4-Hydroxybutyric aciduria.
Rahbeeni Z; Ozand PT; Rashed M; Gascon GG; al Nasser M; al Odaib A; Amoudi M; Nester M; al Garawi S; Brismar J
Brain Dev; 1994 Nov; 16 Suppl():64-71. PubMed ID: 7726383
[TBL] [Abstract][Full Text] [Related]
3. Clinical and brain 18fluoro-2-deoxyglucose positron emission tomographic findings in ethylmalonic aciduria, a progressive neurometabolic disease.
al-Essa MA; al-Shamsan LA; Ozand PT
Eur J Paediatr Neurol; 1999; 3(3):125-7. PubMed ID: 10461568
[TBL] [Abstract][Full Text] [Related]
4. Cerebral fluorine-18 labeled 2-fluoro-2-deoxyglucose positron emission tomography (FDG PET), MRI, and clinical observations in a patient with infantile G(M1) gangliosidosis.
Al-Essa MA; Bakheet SM; Patay ZJ; Nounou RM; Ozand PT
Brain Dev; 1999 Dec; 21(8):559-62. PubMed ID: 10598059
[TBL] [Abstract][Full Text] [Related]
5. Glutaric aciduria type II: observations in seven patients with neonatal- and late-onset disease.
al-Essa MA; Rashed MS; Bakheet SM; Patay ZJ; Ozand PT
J Perinatol; 2000 Mar; 20(2):120-8. PubMed ID: 10785889
[TBL] [Abstract][Full Text] [Related]
6. 18Fluoro-2-deoxyglucose (18FDG) PET scan of the brain in type IV 3-methylglutaconic aciduria: clinical and MRI correlations.
Al-Essa M; Bakheet S; Al-Shamsan L; Patay Z; Powe J; Ozand PT
Brain Dev; 1999 Jan; 21(1):24-9. PubMed ID: 10082249
[TBL] [Abstract][Full Text] [Related]
7. [Regional cerebral glucose metabolism associated with ataxic gait--an FDG-PET activation study in patients with olivopontocerebellar atrophy].
Mishina M; Senda M; Ohyama M; Ishii K; Kitamura S; Terashi A
Rinsho Shinkeigaku; 1995 Nov; 35(11):1199-204. PubMed ID: 8720328
[TBL] [Abstract][Full Text] [Related]
8. Fluoro-2-deoxyglucose (18FDG) PET scan of the brain in glutaric aciduria type 1: clinical and MRI correlations.
Al-Essa M; Bakheet S; Patay Z; Al-Watban J; Powe J; Joshi S; Ozand PT
Brain Dev; 1998 Aug; 20(5):295-301. PubMed ID: 9760998
[TBL] [Abstract][Full Text] [Related]
9. Clinical and cerebral FDG PET scan in a patient with Krabbe's disease.
Al-Essa MA; Bakheet SM; Patay ZJ; Powe JE; Ozand PT
Pediatr Neurol; 2000 Jan; 22(1):44-7. PubMed ID: 10669205
[TBL] [Abstract][Full Text] [Related]
10. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
11. Clinical, fluorine-18 labeled 2-fluoro-2-deoxyglucose positron emission tomography of the brain, MR spectroscopy, and therapeutic attempts in methylenetetrahydrofolate reductase deficiency.
Al-Essa MA; Al Amir A; Rashed M; Al Jishi E; Abutaleb A; Mobaireek K; Shin YS; Ozand PT
Brain Dev; 1999 Jul; 21(5):345-9. PubMed ID: 10413024
[TBL] [Abstract][Full Text] [Related]
12. Positron Emission Tomography and Magnetic Resonance Imaging of the Brain in Fabry Disease: A Nationwide, Long-Time, Prospective Follow-Up.
Korsholm K; Feldt-Rasmussen U; Granqvist H; Højgaard L; Bollinger B; Rasmussen AK; Law I
PLoS One; 2015; 10(12):e0143940. PubMed ID: 26629990
[TBL] [Abstract][Full Text] [Related]
13. Cholangiocarcinoma associated with limbic encephalitis and early cerebral abnormalities detected by 2-deoxy-2-[fluorine-18]fluoro-D-glucose integrated with computed tomography-positron emission tomography: a case report.
Schmidt SL; Schmidt JJ; Tolentino JC; Ferreira CG; de Almeida SA; Alvarenga RP; Simoes EN; Schmidt GJ; Canedo NH; Chimelli L
J Med Case Rep; 2016 Jul; 10():200. PubMed ID: 27439460
[TBL] [Abstract][Full Text] [Related]
14. The role of FDG-PET, HMPAO-SPET and MRI in the detection of brain involvement in patients with systemic lupus erythematosus.
Kao CH; Lan JL; ChangLai SP; Liao KK; Yen RF; Chieng PU
Eur J Nucl Med; 1999 Feb; 26(2):129-34. PubMed ID: 9933346
[TBL] [Abstract][Full Text] [Related]
15. 18Fluoro-2-deoxyglucose (18FDG) PET scan of the brain in propionic acidemia: clinical and MRI correlations.
Al-Essa M; Bakheet S; Patay Z; Al-Shamsan L; Al-Sonbul A; Al-Watban J; Powe J; Ozand PT
Brain Dev; 1999 Jul; 21(5):312-7. PubMed ID: 10413018
[TBL] [Abstract][Full Text] [Related]
16. The Marinesco-Sjögren syndrome examined by computed tomography, magnetic resonance, and 18F-2-fluoro-2-deoxy-D-glucose and positron emission tomography.
Bromberg MB; Junck L; Gebarski SS; McLean MJ; Gilman S
Arch Neurol; 1990 Nov; 47(11):1239-42. PubMed ID: 2241622
[TBL] [Abstract][Full Text] [Related]
17. Brain 18F-FDG-PET characteristics in patients with paraneoplastic neurological syndrome and its correlation with clinical and MRI findings.
Masangkay N; Basu S; Moghbel M; Kwee T; Alavi A
Nucl Med Commun; 2014 Oct; 35(10):1038-46. PubMed ID: 25023997
[TBL] [Abstract][Full Text] [Related]
18. Neuroimaging in infantile autism.
Schifter T; Hoffman JM; Hatten HP; Hanson MW; Coleman RE; DeLong GR
J Child Neurol; 1994 Apr; 9(2):155-61. PubMed ID: 8006366
[TBL] [Abstract][Full Text] [Related]
19. Monitoring of 4-hydroxybutyric acid levels in body fluids during vigabatrin treatment in succinic semialdehyde dehydrogenase deficiency.
Ergezinger K; Jeschke R; Frauendienst-Egger G; Korall H; Gibson KM; Schuster VH
Ann Neurol; 2003 Nov; 54(5):686-9. PubMed ID: 14595661
[TBL] [Abstract][Full Text] [Related]
20. Clinical evaluation of interictal fluorine-18-fluorodeoxyglucose PET in partial epilepsy.
Henry TR; Engel J; Mazziotta JC
J Nucl Med; 1993 Nov; 34(11):1892-8. PubMed ID: 8229230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
